PRUDENTIAL FINANCIAL INC - BIOHAVEN PHARMACTL HLDG CO L ownership

BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 287 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q4 2021. The put-call ratio across all filers is 1.02 and the average weighting 0.8%.

Quarter-by-quarter ownership
PRUDENTIAL FINANCIAL INC ownership history of BIOHAVEN PHARMACTL HLDG CO L
ValueSharesWeighting
Q3 2022$684,000
-13.2%
4,511
-16.6%
0.00%0.0%
Q2 2022$788,000
+19.0%
5,406
-3.1%
0.00%0.0%
Q1 2022$662,000
+0.3%
5,580
+25.2%
0.00%0.0%
Q4 2021$660,000
-73.3%
4,458
-75.0%
0.00%
-66.7%
Q3 2021$2,471,000
+465.4%
17,811
+296.2%
0.00%
+200.0%
Q2 2021$437,000
+54.4%
4,496
+8.4%
0.00%
Q1 2021$283,000
-18.9%
4,146
+1.9%
0.00%
-100.0%
Q4 2020$349,000
+33.7%
4,069
+1.4%
0.00%
Q3 2020$261,000
+14.0%
4,013
+28.0%
0.00%
Q2 2020$229,000
-77.3%
3,134
-87.0%
0.00%
-100.0%
Q3 2019$1,009,000
-72.3%
24,188
-70.9%
0.00%
-66.7%
Q2 2019$3,645,00083,2170.01%
Other shareholders
BIOHAVEN PHARMACTL HLDG CO L shareholders Q4 2021
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 900,844$136,181,00079.57%
RP Management, LLC 1,111,111$167,967,00077.60%
JET CAPITAL INVESTORS L P 1,707,500$258,942,00053.95%
Alpine Global Management, LLC 373,999$56,537,00013.23%
Chicago Capital Management, LLC 154,585$23,443,00012.75%
FIFTH LANE CAPITAL, LP 140,000$21,164,00011.03%
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 3,784,482$572,100,000,00010.85%
Eversept Partners, LP 637,139$96,316,3038.35%
EQUITEC PROPRIETARY MARKETS, LLC 187,100$28,284,0007.45%
HARVEST MANAGEMENT LLC 48,503$7,332,0005.92%
View complete list of BIOHAVEN PHARMACTL HLDG CO L shareholders